48 related articles for article (PubMed ID: 32915507)
1. Routine haematology parameters in COVID-19 patients and clinical outcome: A Belgian single-centre study.
Demeester S; Demuyser T; Fauconnier C; Heestermans R; Orlando C; Depreter B; Jochmans K
Int J Lab Hematol; 2020 Dec; 42(6):e252-e255. PubMed ID: 32915507
[No Abstract] [Full Text] [Related]
2. Platelets in Coronavirus Disease 2019.
Larsen JB; Pasalic L; Hvas AM
Semin Thromb Hemost; 2020 Oct; 46(7):823-825. PubMed ID: 32356294
[No Abstract] [Full Text] [Related]
3. Association between D-Dimer levels and mortality in patients with coronavirus disease 2019 (COVID-19): a systematic review and pooled analysis.
Sakka M; Connors JM; Hékimian G; Martin-Toutain I; Crichi B; Colmegna I; Bonnefont-Rousselot D; Farge D; Frere C
J Med Vasc; 2020 Sep; 45(5):268-274. PubMed ID: 32862984
[TBL] [Abstract][Full Text] [Related]
4. Thromboelastography Profiles of Critically Ill Patients With Coronavirus Disease 2019.
Yuriditsky E; Horowitz JM; Merchan C; Ahuja T; Brosnahan SB; McVoy L; Berger JS
Crit Care Med; 2020 Sep; 48(9):1319-1326. PubMed ID: 32618696
[TBL] [Abstract][Full Text] [Related]
5. Echocardiographic Findings in Patients With COVID-19 Pneumonia.
Mahmoud-Elsayed HM; Moody WE; Bradlow WM; Khan-Kheil AM; Senior J; Hudsmith LE; Steeds RP
Can J Cardiol; 2020 Aug; 36(8):1203-1207. PubMed ID: 32474111
[TBL] [Abstract][Full Text] [Related]
6. Does glycemic control rescue type 2 diabetes patients from COVID-19-related deaths?
Naruse K
J Diabetes Investig; 2020 Jul; 11(4):792-794. PubMed ID: 32521120
[TBL] [Abstract][Full Text] [Related]
7. Albumin and total bilirubin for severity and mortality in coronavirus disease 2019 patients.
Wang Y; Shi L; Wang Y; Duan G; Yang H
J Clin Lab Anal; 2020 Jul; 34(7):e23412. PubMed ID: 32745325
[No Abstract] [Full Text] [Related]
8. D-dimer levels on admission and all-cause mortality risk in COVID-19 patients: a meta-analysis.
Simadibrata DM; Lubis AM
Epidemiol Infect; 2020 Sep; 148():e202. PubMed ID: 32892787
[TBL] [Abstract][Full Text] [Related]
9. How can we better predict pulmonary blood clots in patients hospitalised for COVID-19?
Bertoletti L; Huisman MV
Eur Respir J; 2020 Oct; 56(4):. PubMed ID: 32907888
[TBL] [Abstract][Full Text] [Related]
10. Hematologic predictors of mortality in hospitalized patients with COVID-19: a comparative study.
Mousavi SA; Rad S; Rostami T; Rostami M; Mousavi SA; Mirhoseini SA; Kiumarsi A
Hematology; 2020 Dec; 25(1):383-388. PubMed ID: 33124971
[No Abstract] [Full Text] [Related]
11. Differential white blood cell count in the COVID-19: A cross-sectional study of 148 patients.
Anurag A; Jha PK; Kumar A
Diabetes Metab Syndr; 2020; 14(6):2099-2102. PubMed ID: 33160224
[TBL] [Abstract][Full Text] [Related]
12. Characteristics and Outcomes of Patients Infected with SARS-CoV-2 in Israel: Correlation between Laboratory Findings on Admission to Emergency Department and Subsequent Respiratory Failure.
Elhadad D; Bronstein Y; Yana M; Baris H; Levinger U; Shapiro M; Sharon N
Isr Med Assoc J; 2020 Oct; 22(10):605-611. PubMed ID: 33070482
[TBL] [Abstract][Full Text] [Related]
13. Routine haematological parameters in COVID-19 prognosis.
Pereyra D; Heber S; Jilma B; Zoufaly A; Assinger A
Lancet Haematol; 2020 Oct; 7(10):e709. PubMed ID: 32976747
[No Abstract] [Full Text] [Related]
14. Associations between hematological parameters and disease severity in patients with SARS-CoV-2 infection.
Lin S; Mao W; Zou Q; Lu S; Zheng S
J Clin Lab Anal; 2021 Jan; 35(1):e23604. PubMed ID: 33184946
[TBL] [Abstract][Full Text] [Related]
15. Lymphocyte percentage and hemoglobin as a joint parameter for the prediction of severe and nonsevere COVID-19: a preliminary study.
Zhang W; Zhang Z; Ye Y; Luo Y; Pan S; Qi H; Yu Z; Qu J
Ann Transl Med; 2020 Oct; 8(19):1231. PubMed ID: 33178763
[TBL] [Abstract][Full Text] [Related]
16. The role of haematological parameters in patients with COVID-19 and influenza virus infection.
Kazancioglu S; Bastug A; Ozbay BO; Kemirtlek N; Bodur H
Epidemiol Infect; 2020 Nov; 148():e272. PubMed ID: 33148349
[TBL] [Abstract][Full Text] [Related]
17. A biological profile for diagnosis and outcome of COVID-19 patients.
Khourssaji M; Chapelle V; Evenepoel A; Belkhir L; Yombi JC; van Dievoet MA; Saussoy P; Coche E; Fillée C; Constantinescu SN; Rodriguez-Villalobos H; Defour JP; Gruson D
Clin Chem Lab Med; 2020 Oct; 58(12):2141-2150. PubMed ID: 33064667
[TBL] [Abstract][Full Text] [Related]
18. Do initial hematologic indices predict the severity of COVID-19 patients?
Asan A; Üstündağ Y; Koca N; Şimşek A; Sayan HE; Parildar H; Dalyan Cilo B; Huysal K
Turk J Med Sci; 2021 Feb; 51(1):39-44. PubMed ID: 33003692
[TBL] [Abstract][Full Text] [Related]
19. Monocyte volumetric parameters and lymph index are increased in SARS-CoV-2 infection.
Zeng X; Xing H; Wei Y; Tang Z; Lu X; Wang Z; Liu Y; Xu L; Hu L; Wang L; Xu D
Int J Lab Hematol; 2020 Dec; 42(6):e266-e269. PubMed ID: 32981233
[No Abstract] [Full Text] [Related]
20. Covid-19: contribution of clinical characteristics and laboratory features for early detection of patients with high risk of severe evolution.
Sepulchre E; Pittie G; Stojkovic V; Haesbroek G; Crama Y; Schyns M; Paridaens H; de Marchin J; Degesves S; Biemar C; Boccar S; Senterre JM; Minon JM
Acta Clin Belg; 2022 Apr; 77(2):261-267. PubMed ID: 32935644
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
